Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $38788.0.

  • Cryo Cell International's Capital Expenditures fell 7911.32% to $38788.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $171597.0, marking a year-over-year decrease of 9582.52%. This contributed to the annual value of $2.4 million for FY2024, which is 6485.28% down from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's Capital Expenditures is $38788.0, which was down 7911.32% from $62408.0 recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Capital Expenditures ranged from a high of $11.2 million in Q3 2022 and a low of -$25011.0 during Q4 2022
  • Its 5-year average for Capital Expenditures is $1.2 million, with a median of $306970.0 in 2022.
  • In the last 5 years, Cryo Cell International's Capital Expenditures skyrocketed by 7055184.5% in 2021 and then crashed by 10893.27% in 2022.
  • Cryo Cell International's Capital Expenditures (Quarter) stood at $279993.0 in 2021, then crashed by 108.93% to -$25011.0 in 2022, then soared by 6956.64% to $1.7 million in 2023, then plummeted by 99.51% to $8348.0 in 2024, then soared by 364.64% to $38788.0 in 2025.
  • Its Capital Expenditures stands at $38788.0 for Q3 2025, versus $62408.0 for Q2 2025 and $62053.0 for Q1 2025.